Ototoxicity in Patients With MoM Hip Bearings

Recruiting Observational Study
Ototoxic Hearing Loss Cobalt Poisoning Chromium Causing Toxic Effect Arthroplasty Complications
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Reinier Haga Orthopedisch Centrum · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patients with high and low plasma metal concentrations.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * all MoM patients from the different clinics * revision MoM * willing to participate * speak/write the Dutch language Exclusion Criteria: * Not willing to participate * previous ENT surgery or ENT pathology
Contacts

Nina Mathijssen, Dr

+31(0)79 206 5583

n.mathijssen@rhoc.nl

CONTACT

Maarten Koper, dr.

+31(0)79 206 5583

m.koper@rhoc.nl

CONTACT